Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $8.42 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 42.34.
Market Cap
8.42T
Revenue
4.59T
Profits
198.88B
PE Ratio
42.34
Profit Margin
4.33%
Dividend Yield
0.42%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 982.77B | 0.32% | 3,015,041 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 556.77B | 1.27% | 8,518,349 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 406.38B | 6.25% | 9,912,770 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 369.32B | 1.43% | 5,818,614 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 285.22B | 1.41% | 10,521,234 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 273.23B | 0.86% | 1,489,610 | 60.44B |
| 7 | NVS | Novartis AG | 272.41B | 1.26% | 1,399,966 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 203.35B | 6.23% | 17,141,298 | 50.57B |
| 9 | AMGN | Amgen Inc. | 186.05B | 2.11% | 2,520,964 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 172.44B | -0.13% | 1,524,578 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 155.03B | 0.90% | 8,126,313 | 29.74B |
| 12 | ABT | Abbott Laboratories | 152.98B | -0.66% | 11,458,236 | 45.13B |
| 13 | PFE | Pfizer Inc. | 142.94B | -0.52% | 41,119,107 | 63.32B |
| 14 | ISRG | Intuitive Surgical, Inc. | 142.71B | -0.94% | 2,680,660 | 10.58B |
| 15 | CVS | CVS Health Corporation | 129.25B | 3.03% | 9,810,553 | 405.62B |
| 16 | DHR | Danaher Corporation | 126.12B | 0.58% | 3,691,893 | 24.78B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 118.47B | 3.36% | 2,034,574 | 12.22B |
| 18 | SYK | Stryker Corporation | 116.81B | -1.01% | 2,395,483 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 111.70B | 1.30% | 15,961,355 | 48.48B |
| 20 | GSK | GSK plc | 101.65B | 0.14% | 3,735,159 | 43.29B |
| 21 | MDT | Medtronic plc | 101.47B | -0.09% | 10,018,919 | 36.36B |
| 22 | SNY | Sanofi | 99.57B | -1.42% | 5,751,326 | 54.60B |
| 23 | MCK | McKesson Corporation | 87.21B | -0.77% | 1,454,600 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 85.74B | 1.63% | 1,172,120 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 83.63B | 0.49% | 1,632,623 | 76.39B |
| 26 | CI | The Cigna Group | 74.62B | 1.01% | 1,498,645 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 65.89B | -2.12% | 16,784,722 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 62.32B | 0.42% | 1,604,298 | 14.92B |
| 29 | ARGX | argenx SE | 56.65B | 2.97% | 432,891 | 4.74B |
| 30 | COR | Cencora, Inc. | 52.78B | -0.20% | 1,657,680 | 328.68B |
| 31 | CAH | Cardinal Health, Inc. | 52.17B | 0.44% | 2,886,149 | 250.74B |
| 32 | EW | Edwards Lifesciences Corporation | 49.45B | -1.69% | 3,506,790 | 6.30B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 49.05B | -1.02% | 2,351,300 | 28.34B |
| 34 | MDLN | Medline Inc. | 45.60B | -3.42% | 6,692,598 | 29.14B |
| 35 | HUM | Humana Inc. | 43.31B | 0.02% | 1,706,150 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 43.05B | -2.91% | 627,647 | 4.45B |
| 37 | BDX | Becton, Dickinson and Company | 38.77B | -2.27% | 3,642,816 | 22.23B |
| 38 | HLN | Haleon plc | 38.75B | -2.12% | 12,948,214 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.24B | 2.99% | 1,420,699 | 4.29B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 37.49B | 2.29% | 6,111,094 | 17.35B |
| 41 | A | Agilent Technologies, Inc. | 35.72B | -0.45% | 2,187,096 | 7.23B |
| 42 | RVMD | Revolution Medicines, Inc. | 35.25B | 1.73% | 3,129,267 | - |
| 43 | WAT | Waters Corporation | 35.18B | 0.79% | 821,657 | 3.77B |
| 44 | NTRA | Natera, Inc. | 32.77B | -1.13% | 1,577,833 | 2.50B |
| 45 | ALC | Alcon Inc. | 31.85B | 0.77% | 1,592,109 | 10.63B |
| 46 | ZTS | Zoetis Inc. | 31.82B | -3.58% | 6,772,601 | 9.53B |
| 47 | CNC | Centene Corporation | 31.44B | 4.36% | 4,859,415 | 178.33B |
| 48 | RPRX | Royalty Pharma plc | 30.85B | 1.15% | 4,091,976 | 2.44B |
| 49 | ONC | BeOne Medicines AG | 30.22B | 0.61% | 205,159 | 5.70B |
| 50 | BIIB | Biogen Inc. | 29.48B | 1.59% | 1,675,111 | 9.94B |
| 51 | IQV | IQVIA Holdings Inc. | 28.01B | 0.02% | 2,136,124 | 16.63B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 27.58B | -1.54% | 5,823,217 | 20.98B |
| 53 | RMD | ResMed Inc. | 27.22B | -0.10% | 1,204,047 | 5.54B |
| 54 | DXCM | DexCom, Inc. | 26.65B | -4.69% | 5,570,881 | 4.82B |
| 55 | PHG | Koninklijke Philips N.V. | 25.80B | 0.75% | 1,200,944 | 20.34B |
| 56 | VEEV | Veeva Systems Inc. | 24.88B | -0.09% | 2,449,701 | 3.32B |
| 57 | ILMN | Illumina, Inc. | 24.42B | -0.34% | 1,791,165 | 4.39B |
| 58 | MRNA | Moderna, Inc. | 23.55B | -7.22% | 8,363,487 | 2.23B |
| 59 | MTD | Mettler-Toledo International Inc. | 23.52B | 1.68% | 325,803 | 4.09B |
| 60 | WST | West Pharmaceutical Services, Inc. | 23.29B | 0.54% | 842,929 | 3.22B |
| 61 | UTHR | United Therapeutics Corporation | 22.85B | 0.32% | 620,875 | 3.17B |
| 62 | BNTX | BioNTech SE | 22.81B | -0.77% | 887,521 | 3.23B |
| 63 | ROIV | Roivant Sciences Ltd. | 22.48B | -0.57% | 6,878,142 | 8.26M |
| 64 | DGX | Quest Diagnostics Incorporated | 21.43B | -0.73% | 904,816 | 11.28B |
| 65 | INSM | Insmed Incorporated | 21.37B | 2.93% | 4,257,432 | 819.56M |
| 66 | LH | Labcorp Holdings Inc. | 20.86B | -0.54% | 784,900 | 14.14B |
| 67 | INCY | Incyte Corporation | 20.71B | 5.54% | 2,204,989 | 5.36B |
| 68 | STE | STERIS plc | 19.53B | -1.09% | 1,026,838 | 5.94B |
| 69 | VTRS | Viatris Inc. | 17.91B | 0.07% | 12,531,234 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 17.08B | -2.24% | 1,444,664 | 1.08B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 16.85B | -1.00% | 2,519,754 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 16.25B | 2.10% | 1,008,894 | 3.10B |
| 73 | GMAB | Genmab A/S | 15.56B | 1.35% | 1,593,105 | 3.90B |
| 74 | THC | Tenet Healthcare Corporation | 15.40B | 3.58% | 1,310,246 | 21.46B |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 14.17B | 0.56% | 979,966 | 4.44B |
| 76 | ASND | Ascendis Pharma A/S | 14.16B | -1.23% | 560,738 | 998.25M |
| 77 | BTSG | BrightSpring Health Services, Inc. | 14.00B | 1.43% | 2,477,030 | 13.65B |
| 78 | BBIO | BridgeBio Pharma, Inc. | 13.50B | 4.00% | 2,539,873 | 579.96M |
| 79 | DVA | DaVita Inc. | 13.46B | 0.85% | 783,121 | 13.84B |
| 80 | MEDP | Medpace Holdings, Inc. | 13.01B | -0.99% | 385,386 | 2.68B |
| 81 | EXEL | Exelixis, Inc. | 12.91B | -1.08% | 3,504,387 | 2.38B |
| 82 | COO | The Cooper Companies, Inc. | 12.76B | -0.74% | 3,175,828 | 4.23B |
| 83 | AXSM | Axsome Therapeutics, Inc. | 12.75B | -1.06% | 814,132 | 708.24M |
| 84 | SOLV | Solventum Corporation | 12.74B | -2.48% | 2,008,891 | 8.26B |
| 85 | FMS | Fresenius Medical Care AG | 12.68B | -0.85% | 488,456 | 22.32B |
| 86 | IONS | Ionis Pharmaceuticals, Inc. | 12.54B | 2.39% | 1,956,125 | 1.06B |
| 87 | SNN | Smith & Nephew plc | 12.52B | -2.29% | 1,156,389 | 6.16B |
| 88 | ALGN | Align Technology, Inc. | 12.44B | -4.57% | 1,277,764 | 4.10B |
| 89 | PEN | Penumbra, Inc. | 12.44B | -0.32% | 201,810 | 1.45B |
| 90 | ELAN | Elanco Animal Health Incorporated | 11.94B | -1.32% | 5,350,053 | 4.89B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.82B | 1.41% | 281,844 | 1.13B |
| 92 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.55B | 0.22% | 1,510,512 | 622.01M |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 11.38B | 4.67% | 3,228,783 | 3.58B |
| 94 | SMMT | Summit Therapeutics Inc. | 11.08B | 3.85% | 7,392,683 | - |
| 95 | RVTY | Revvity, Inc. | 11.05B | -0.96% | 1,187,952 | 2.90B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 10.80B | 2.21% | 3,014,592 | 3.24B |
| 97 | ICLR | ICON Public Limited Company | 10.78B | -3.61% | 918,795 | 8.25B |
| 98 | GMED | Globus Medical, Inc. | 10.75B | -0.05% | 2,007,874 | 3.10B |
| 99 | CYTK | Cytokinetics, Incorporated | 10.75B | 0.50% | 2,888,383 | 105.82M |
| 100 | MOH | Molina Healthcare, Inc. | 10.28B | 1.05% | 887,365 | 43.10B |
| 101 | BAX | Baxter International Inc. | 10.15B | -1.16% | 4,801,018 | 11.32B |
| 102 | KRYS | Krystal Biotech, Inc. | 10.12B | -1.33% | 411,691 | 417.30M |
| 103 | APGE | Apogee Therapeutics, Inc. | 9.93B | 46.66% | 61,663,544 | - |
| 104 | EHC | Encompass Health Corporation | 9.79B | 0.66% | 1,128,461 | 6.07B |
| 105 | NUVL | Nuvalent, Inc. | 9.75B | -0.01% | 2,094,308 | - |
| 106 | PODD | Insulet Corporation | 9.63B | -4.66% | 1,685,322 | 2.90B |
| 107 | ENSG | The Ensign Group, Inc. | 9.09B | 2.04% | 889,206 | 5.27B |
| 108 | HSIC | Henry Schein, Inc. | 8.96B | -1.56% | 1,029,142 | 13.38B |
| 109 | CRL | Charles River Laboratories International, Inc. | 8.75B | -1.86% | 670,146 | 4.03B |
| 110 | SYRE | Spyre Therapeutics, Inc. | 8.71B | 13.56% | 2,805,256 | - |
| 111 | TECH | Bio-Techne Corporation | 8.71B | -4.02% | 2,034,835 | 1.21B |
| 112 | UHS | Universal Health Services, Inc. | 8.63B | 1.04% | 669,447 | 17.76B |
| 113 | BRKR | Bruker Corporation | 8.61B | -1.14% | 2,481,554 | 3.46B |
| 114 | OSCR | Oscar Health, Inc. | 8.60B | 0.49% | 5,192,333 | 13.30B |
| 115 | TEM | Tempus AI, Inc. | 8.59B | -5.88% | 5,170,889 | 1.36B |
| 116 | CORT | Corcept Therapeutics Incorporated | 8.56B | -0.25% | 882,898 | 769.10M |
| 117 | PRAX | Praxis Precision Medicines, Inc. | 8.46B | 7.47% | 657,228 | 7.46M |
| 118 | HALO | Halozyme Therapeutics, Inc. | 8.18B | 0.64% | 1,054,256 | 1.51B |
| 119 | KYMR | Kymera Therapeutics, Inc. | 8.18B | 9.97% | 2,891,279 | 51.48M |
| 120 | ABVX | ABIVAX Société Anonyme | 7.83B | 2.53% | 2,237,686 | 5.67M |
| 121 | IMVT | Immunovant, Inc. | 7.82B | 7.81% | 2,808,164 | - |
| 122 | HIMS | Hims & Hers Health, Inc. | 7.76B | -5.44% | 22,866,865 | 2.37B |
| 123 | TGTX | TG Therapeutics, Inc. | 7.71B | 2.22% | 3,979,262 | 700.35M |
| 124 | GKOS | Glaukos Corporation | 7.70B | 0.39% | 806,569 | 551.35M |
| 125 | ALKS | Alkermes plc | 7.67B | 2.29% | 3,227,468 | 1.56B |
| 126 | ATR | AptarGroup, Inc. | 7.66B | -0.27% | 468,368 | 3.87B |
| 127 | IBRX | ImmunityBio, Inc. | 7.56B | -1.90% | 9,888,330 | 140.98M |
| 128 | PCVX | Vaxcyte, Inc. | 7.52B | 1.30% | 1,473,744 | - |
| 129 | BIO | Bio-Rad Laboratories, Inc. | 7.52B | -0.47% | 236,801 | 2.59B |
| 130 | QGEN | Qiagen N.V. | 7.50B | -1.81% | 2,624,822 | 2.10B |
| 131 | PTGX | Protagonist Therapeutics, Inc. | 7.40B | 1.92% | 1,193,689 | 74.06M |
| 132 | RGEN | Repligen Corporation | 7.14B | -4.13% | 865,916 | 763.34M |
| 133 | HQY | HealthEquity, Inc. | 7.07B | -0.70% | 850,356 | 1.34B |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.95B | 4.75% | 1,319,798 | 217.17M |
| 135 | LNTH | Lantheus Holdings, Inc. | 6.91B | 2.25% | 630,400 | 1.55B |
| 136 | PTCT | PTC Therapeutics, Inc. | 6.72B | 2.51% | 2,414,052 | 827.11M |
| 137 | LQDA | Liquidia Corporation | 6.71B | 6.22% | 2,908,574 | 288.07M |
| 138 | MIRM | Mirum Pharmaceuticals, Inc. | 6.57B | 0.60% | 1,207,238 | 569.61M |
| 139 | AVTR | Avantor, Inc. | 6.38B | -2.40% | 7,390,973 | 6.55B |
| 140 | GRFS | Grifols, S.A. | 6.28B | -1.62% | 691,080 | 8.58B |
| 141 | CNTA | Centessa Pharmaceuticals plc | 6.22B | 0.40% | 3,758,569 | 15.00M |
| 142 | COGT | Cogent Biosciences, Inc. | 6.13B | 3.76% | 3,175,459 | - |
| 143 | PACS | PACS Group, Inc. | 5.98B | 3.22% | 899,275 | 5.43B |
| 144 | SRRK | Scholar Rock Holding Corporation | 5.89B | 3.93% | 2,140,287 | - |
| 145 | CGON | CG Oncology, Inc. | 5.84B | 8.46% | 1,244,076 | 5.07M |
| 146 | BLTE | Belite Bio, Inc | 5.79B | 0.65% | 172,446 | - |
| 147 | CHE | Chemed Corporation | 5.76B | -0.05% | 205,216 | 2.54B |
| 148 | LEGN | Legend Biotech Corporation | 5.45B | 5.05% | 3,664,574 | 1.14B |
| 149 | TFX | Teleflex Incorporated | 5.39B | -4.20% | 722,851 | 2.13B |
| 150 | HNGE | Hinge Health, Inc. | 5.33B | -0.82% | 2,307,563 | 646.34M |
| 151 | BLCO | Bausch + Lomb Corporation | 5.32B | 0.40% | 438,649 | 5.21B |
| 152 | TWST | Twist Bioscience Corporation | 5.30B | -2.73% | 2,354,723 | 409.48M |
| 153 | XENE | Xenon Pharmaceuticals Inc. | 5.30B | 3.55% | 1,856,354 | 7.50M |
| 154 | LGND | Ligand Pharmaceuticals Incorporated | 5.25B | -4.62% | 819,521 | 274.48M |
| 155 | CRSP | CRISPR Therapeutics AG | 5.24B | 0.50% | 1,135,638 | 4.10M |
| 156 | RGC | Regencell Bioscience Holdings Limited | 5.21B | -12.49% | 538,020 | - |
| 157 | ORKA | Oruka Therapeutics, Inc. | 5.15B | 18.03% | 4,201,126 | - |
| 158 | AMRX | Amneal Pharmaceuticals, Inc. | 5.14B | -0.62% | 1,794,259 | 3.05B |
| 159 | TVTX | Travere Therapeutics, Inc. | 5.12B | -0.07% | 1,742,522 | 536.20M |
| 160 | CAI | Caris Life Sciences, Inc. | 4.89B | -6.28% | 3,023,468 | 907.29M |
| 161 | DNTH | Dianthus Therapeutics, Inc. | 4.78B | 5.92% | 1,021,053 | 1.34M |
| 162 | ERAS | Erasca, Inc. | 4.69B | 10.31% | 8,996,574 | - |
| 163 | BLLN | BillionToOne, Inc. | 4.63B | -4.21% | 807,638 | 354.54M |
| 164 | STVN | Stevanato Group S.p.A. | 4.62B | -3.42% | 381,540 | 1.39B |
| 165 | SHC | Sotera Health Company | 4.49B | -0.51% | 1,739,211 | 1.19B |
| 166 | ALHC | Alignment Healthcare, Inc. | 4.40B | -2.61% | 5,416,739 | 4.26B |
| 167 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.40B | 3.67% | 609,114 | 754.05M |
| 168 | CELC | Celcuity Inc. | 4.39B | 2.47% | 884,644 | - |
| 169 | RDNT | RadNet, Inc. | 4.38B | 3.76% | 870,616 | 2.14B |
| 170 | LIVN | LivaNova PLC | 4.32B | 0.27% | 689,740 | 1.43B |
| 171 | MANE | Veradermics, Incorporated | 4.29B | 9.50% | 896,789 | - |
| 172 | VCYT | Veracyte, Inc. | 4.24B | -0.82% | 967,186 | 541.74M |
| 173 | TXG | 10x Genomics, Inc. | 4.18B | -5.24% | 4,267,771 | 638.78M |
| 174 | NVST | Envista Holdings Corporation | 4.15B | -1.54% | 2,419,582 | 2.81B |
| 175 | TNGX | Tango Therapeutics, Inc. | 4.12B | 1.89% | 6,313,894 | 56.99M |
| 176 | DFTX | Definium Therapeutics, Inc. | 4.00B | 49.80% | 20,142,929 | - |
| 177 | MMED | MiniMed Group, Inc. | 3.99B | -3.72% | 631,545 | 3.10B |
| 178 | MMSI | Merit Medical Systems, Inc. | 3.97B | -1.07% | 606,003 | 1.54B |
| 179 | EWTX | Edgewise Therapeutics, Inc. | 3.93B | -0.84% | 1,158,465 | - |
| 180 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | - | 2,097,513 | 596.96M |
| 181 | DNLI | Denali Therapeutics Inc. | 3.82B | 3.17% | 1,612,585 | - |
| 182 | ACAD | ACADIA Pharmaceuticals Inc. | 3.78B | 2.17% | 1,904,396 | 1.10B |
| 183 | RLAY | Relay Therapeutics, Inc. | 3.77B | 8.82% | 4,414,523 | 10.68M |
| 184 | VKTX | Viking Therapeutics, Inc. | 3.76B | 6.55% | 3,323,575 | - |
| 185 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.73B | -1.37% | 964,248 | 18.07M |
| 186 | DOCS | Doximity, Inc. | 3.67B | -1.91% | 3,022,300 | 644.86M |
| 187 | CON | Concentra Group Holdings Parent, Inc. | 3.65B | -0.25% | 660,777 | 2.23B |
| 188 | NAMS | NewAmsterdam Pharma Company N.V. | 3.60B | 3.32% | 2,032,440 | 22.57M |
| 189 | LFST | LifeStance Health Group, Inc. | 3.57B | 2.51% | 4,841,228 | 1.49B |
| 190 | BEAM | Beam Therapeutics Inc. | 3.54B | 4.07% | 2,603,285 | 164.01M |
| 191 | OGN | Organon & Co. | 3.52B | -0.22% | 2,217,755 | 6.16B |
| 192 | PBLS | Parabilis Medicines, Inc. | 3.51B | 6.54% | 831,128 | - |
| 193 | TLX | Telix Pharmaceuticals Limited | 3.46B | -0.89% | 140,828 | 803.79M |
| 194 | DYN | Dyne Therapeutics, Inc. | 3.45B | 5.40% | 2,560,456 | - |
| 195 | IRTC | iRhythm Holdings, Inc. | 3.44B | 0.04% | 304,021 | 787.85M |
| 196 | RCUS | Arcus Biosciences, Inc. | 3.42B | 12.01% | 3,580,815 | 236.00M |
| 197 | ICUI | ICU Medical, Inc. | 3.40B | -3.01% | 339,872 | 2.16B |
| 198 | OPCH | Option Care Health, Inc. | 3.34B | -3.14% | 1,587,975 | 5.67B |
| 199 | BKD | Brookdale Senior Living Inc. | 3.34B | 2.49% | 2,948,814 | 3.00B |
| 200 | ARQT | Arcutis Biotherapeutics, Inc. | 3.33B | 1.72% | 1,528,828 | 415.62M |
| 201 | WAY | Waystar Holding Corp. | 3.32B | -6.28% | 2,541,016 | 1.16B |
| 202 | WRBY | Warby Parker Inc. | 3.31B | 3.97% | 3,360,550 | 890.57M |
| 203 | HAE | Haemonetics Corporation | 3.30B | -2.21% | 1,171,854 | 1.33B |
| 204 | GPCR | Structure Therapeutics Inc. | 3.23B | 2.25% | 1,149,645 | - |
| 205 | NHC | National HealthCare Corporation | 3.15B | -0.06% | 180,134 | 1.53B |
| 206 | ALMS | Alumis Inc. | 3.14B | 5.08% | 1,435,836 | 8.40M |
| 207 | ITGR | Integer Holdings Corporation | 3.06B | -0.95% | 262,473 | 1.86B |
| 208 | IDYA | IDEAYA Biosciences, Inc. | 3.01B | 9.61% | 1,670,893 | 225.27M |
| 209 | KLRA | Kailera Therapeutics, Inc. | 2.96B | 14.97% | 715,858 | - |
| 210 | PRVA | Privia Health Group, Inc. | 2.96B | -0.76% | 1,009,088 | 2.25B |
| 211 | HTFL | HeartFlow, Inc. | 2.92B | 0.59% | 1,651,982 | 191.42M |
| 212 | RARE | Ultragenyx Pharmaceutical Inc. | 2.85B | 5.79% | 2,067,508 | 670.00M |
| 213 | QURE | uniQure N.V. | 2.80B | -4.10% | 2,812,739 | 18.09M |
| 214 | ELVN | Enliven Therapeutics, Inc. | 2.80B | 1.91% | 2,517,236 | - |
| 215 | ADPT | Adaptive Biotechnologies Corporation | 2.78B | -0.91% | 2,261,989 | 295.41M |
| 216 | VERA | Vera Therapeutics, Inc. | 2.76B | 9.52% | 1,779,985 | - |
| 217 | TARS | Tarsus Pharmaceuticals, Inc. | 2.73B | 0.63% | 788,704 | 535.08M |
| 218 | CLOV | Clover Health Investments, Corp. | 2.71B | 2.80% | 6,937,216 | 2.21B |
| 219 | IRON | Disc Medicine, Inc. | 2.70B | 0.01% | 707,850 | - |
| 220 | GRAL | GRAIL, Inc. | 2.67B | -2.57% | 527,548 | 156.12M |
| 221 | GRDN | Guardian Pharmacy Services, Inc. | 2.65B | -1.23% | 423,482 | 1.46B |
| 222 | CLDX | Celldex Therapeutics, Inc. | 2.62B | 3.02% | 1,957,841 | 865.00K |
| 223 | TMDX | TransMedics Group, Inc. | 2.61B | -4.16% | 842,027 | 635.89M |
| 224 | SUPN | Supernus Pharmaceuticals, Inc. | 2.58B | 0.23% | 513,750 | 776.83M |
| 225 | ESTA | Establishment Labs Holdings Inc. | 2.53B | 1.47% | 620,404 | 229.58M |
| 226 | TRVI | Trevi Therapeutics, Inc. | 2.51B | 2.91% | 2,461,136 | - |
| 227 | AXGN | Axogen, Inc. | 2.39B | 0.25% | 877,521 | 238.11M |
| 228 | BHVN | Biohaven Ltd. | 2.33B | 14.22% | 5,772,485 | - |
| 229 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.32B | 1.67% | 7,405,440 | 885.72M |
| 230 | ACHC | Acadia Healthcare Company, Inc. | 2.32B | 1.37% | 2,493,010 | 3.37B |
| 231 | PHVS | Pharvaris N.V. | 2.31B | 0.61% | 304,133 | - |
| 232 | KOD | Kodiak Sciences Inc. | 2.29B | 1.36% | 611,421 | - |
| 233 | AUPH | Aurinia Pharmaceuticals Inc. | 2.25B | 6.50% | 3,393,739 | 298.30M |
| 234 | NKTR | Nektar Therapeutics | 2.22B | 7.74% | 1,404,622 | 55.63M |
| 235 | NTLA | Intellia Therapeutics, Inc. | 2.20B | 0.51% | 5,103,712 | 66.09M |
| 236 | OCUL | Ocular Therapeutix, Inc. | 2.18B | 5.73% | 5,162,262 | 52.04M |
| 237 | IMNM | Immunome, Inc. | 2.17B | 2.35% | 1,232,774 | 4.02M |
| 238 | PBH | Prestige Consumer Healthcare Inc. | 2.15B | -3.21% | 1,008,271 | 1.09B |
| 239 | MLYS | Mineralys Therapeutics, Inc. | 2.09B | 3.00% | 1,649,979 | - |
| 240 | MBX | MBX Biosciences, Inc. | 2.09B | 2.05% | 660,993 | - |
| 241 | AGIO | Agios Pharmaceuticals, Inc. | 2.09B | 2.75% | 1,378,944 | 66.05M |
| 242 | ZLAB | Zai Lab Limited | 2.08B | 1.65% | 913,248 | 453.28M |
| 243 | VCEL | Vericel Corporation | 2.07B | 0.92% | 596,048 | 292.09M |
| 244 | PGNY | Progyny, Inc. | 2.06B | 0.77% | 1,938,874 | 1.29B |
| 245 | SEM | Select Medical Holdings Corporation | 2.05B | 0.06% | 728,761 | 5.52B |
| 246 | GENB | Generate Biomedicines, Inc. | 2.04B | 9.66% | 1,250,569 | 30.30M |
| 247 | KARD | Kardigan, Inc. | 2.03B | 3.50% | 922,401 | - |
| 248 | XRAY | DENTSPLY SIRONA Inc. | 2.03B | -1.74% | 6,077,180 | 3.68B |
| 249 | LMAT | LeMaitre Vascular, Inc. | 2.02B | -5.68% | 401,525 | 256.28M |
| 250 | NUVB | Nuvation Bio Inc. | 2.01B | 3.60% | 4,159,287 | 143.05M |
| 251 | ADMA | ADMA Biologics, Inc. | 1.99B | 3.13% | 3,704,519 | 509.86M |
| 252 | MESO | Mesoblast Limited | 1.97B | 7.86% | 400,427 | 65.38M |
| 253 | ASTH | Astrana Health, Inc. | 1.96B | 1.07% | 635,731 | 3.53B |
| 254 | VRDN | Viridian Therapeutics, Inc. | 1.95B | 6.01% | 2,549,626 | 70.92M |
| 255 | NEOG | Neogen Corporation | 1.94B | -4.19% | 1,233,909 | 870.56M |
| 256 | HRMY | Harmony Biosciences Holdings, Inc. | 1.94B | 0.45% | 654,241 | 899.11M |
| 257 | STOK | Stoke Therapeutics, Inc. | 1.93B | -0.10% | 617,217 | 32.08M |
| 258 | NRIX | Nurix Therapeutics, Inc. | 1.93B | 6.27% | 2,214,257 | 71.78M |
| 259 | PGEN | Precigen, Inc. | 1.92B | 11.62% | 8,546,938 | 31.60M |
| 260 | BFLY | Butterfly Network, Inc. | 1.90B | -18.31% | 30,866,428 | 102.92M |
| 261 | AGL | agilon health, inc. | 1.89B | -0.61% | 177,296 | 5.82B |
| 262 | MD | Pediatrix Medical Group, Inc. | 1.89B | -0.38% | 927,030 | 1.93B |
| 263 | SGRY | Surgery Partners, Inc. | 1.89B | - | 2,381,845 | 3.34B |
| 264 | LKFT | Lakefront Biotherapeutics NV | 1.88B | 2.26% | 138,496 | 1.20B |
| 265 | TSHA | Taysha Gene Therapies, Inc. | 1.88B | 1.71% | 3,035,821 | 7.47M |
| 266 | SRPT | Sarepta Therapeutics, Inc. | 1.86B | 0.68% | 2,354,967 | 2.18B |
| 267 | RAPP | Rapport Therapeutics, Inc. | 1.83B | 2.28% | 255,446 | 20.00M |
| 268 | IOVA | Iovance Biotherapeutics, Inc. | 1.81B | 3.84% | 11,624,401 | 285.61M |
| 269 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.81B | 3.89% | 1,375,323 | -665.00K |
| 270 | UFPT | UFP Technologies, Inc. | 1.81B | -2.50% | 113,520 | 608.85M |
| 271 | TYRA | Tyra Biosciences, Inc. | 1.79B | 6.43% | 885,503 | - |
| 272 | HCM | HUTCHMED (China) Limited | 1.78B | -2.82% | 54,892 | 548.51M |
| 273 | PLSE | Pulse Biosciences, Inc. | 1.78B | 0.43% | 210,630 | 751.00K |
| 274 | NBTX | Nanobiotix S.A. | 1.76B | -2.87% | 97,148 | 38.27M |
| 275 | OMCL | Omnicell, Inc. | 1.76B | -0.95% | 804,184 | 1.23B |
| 276 | TRLV | Trulieve Cannabis Corp. | 1.75B | -9.70% | 4,068,360 | 1.17B |
| 277 | SION | Sionna Therapeutics, Inc. | 1.75B | 4.10% | 416,416 | - |
| 278 | ABCL | AbCellera Biologics Inc. | 1.75B | 3.80% | 5,500,914 | 79.21M |
| 279 | ANAB | AnaptysBio, Inc. | 1.75B | 4.31% | 407,255 | 232.39M |
| 280 | BHC | Bausch Health Companies Inc. | 1.74B | -2.10% | 2,902,366 | 10.53B |
| 281 | ADUS | Addus HomeCare Corporation | 1.74B | 0.85% | 250,182 | 1.45B |
| 282 | AVAH | Aveanna Healthcare Holdings Inc. | 1.72B | 1.67% | 2,725,592 | 2.52B |
| 283 | SNDX | Syndax Pharmaceuticals, Inc. | 1.71B | 1.68% | 1,836,656 | 217.17M |
| 284 | ANIP | ANI Pharmaceuticals, Inc. | 1.71B | 1.37% | 477,460 | 923.71M |
| 285 | SNDA | Sonida Senior Living, Inc. | 1.71B | 1.67% | 577,232 | 367.34M |
| 286 | URGN | UroGen Pharma Ltd. | 1.70B | 4.23% | 643,467 | 140.49M |
| 287 | PVLA | Palvella Therapeutics, Inc. | 1.70B | 5.08% | 231,425 | - |
| 288 | CMPS | COMPASS Pathways plc | 1.70B | 0.80% | 3,294,361 | - |
| 289 | CAPR | Capricor Therapeutics, Inc. | 1.70B | 3.38% | 1,758,577 | 11.13M |
| 290 | ZYME | Zymeworks Inc. | 1.70B | 0.52% | 530,631 | 81.26M |
| 291 | RXRX | Recursion Pharmaceuticals, Inc. | 1.69B | -1.55% | 14,444,897 | 66.41M |
| 292 | INVA | Innoviva, Inc. | 1.67B | 0.80% | 911,193 | 420.69M |
| 293 | WGS | GeneDx Holdings Corp. | 1.65B | -6.08% | 1,005,424 | 442.68M |
| 294 | MLTX | MoonLake Immunotherapeutics | 1.63B | 15.36% | 3,493,989 | - |
| 295 | VIR | Vir Biotechnology, Inc. | 1.61B | 4.48% | 1,793,644 | 65.50M |
| 296 | BCAX | Bicara Therapeutics Inc. | 1.61B | 5.68% | 831,570 | - |
| 297 | SLS | SELLAS Life Sciences Group, Inc. | 1.59B | 5.96% | 8,101,702 | - |
| 298 | HROW | Harrow, Inc. | 1.58B | -1.07% | 831,169 | 268.68M |
| 299 | ALMR | Alamar Biosciences, Inc. | 1.58B | 3.73% | 257,478 | 87.16M |
| 300 | GLUE | Monte Rosa Therapeutics, Inc. | 1.58B | 1.97% | 1,790,466 | 42.95M |
| 301 | NVCR | NovoCure Limited | 1.58B | -4.69% | 1,956,681 | 674.41M |
| 302 | ARDX | Ardelyx, Inc. | 1.57B | 5.29% | 4,905,851 | 427.68M |
| 303 | SEPN | Septerna, Inc. | 1.57B | -3.65% | 507,455 | 72.26M |
| 304 | HCSG | Healthcare Services Group, Inc. | 1.55B | -1.74% | 1,041,943 | 1.85B |
| 305 | AVBP | ArriVent BioPharma, Inc. | 1.52B | 3.02% | 749,170 | - |
| 306 | GHRS | GH Research PLC | 1.52B | -0.67% | 763,083 | - |
| 307 | IMCR | Immunocore Holdings plc | 1.49B | 2.62% | 893,060 | 412.81M |
| 308 | ATAI | AtaiBeckley Inc. | 1.49B | -0.25% | 5,430,216 | 3.49M |
| 309 | NVAX | Novavax, Inc. | 1.48B | -1.42% | 3,706,432 | 596.34M |
| 310 | AAPG | Ascentage Pharma Group International | 1.48B | 0.06% | 23,109 | 82.08M |
| 311 | FTRE | Fortrea Holdings Inc. | 1.47B | 1.63% | 1,727,449 | 2.71B |
| 312 | DMRA | Damora Therapeutics, Inc. | 1.47B | 12.51% | 554,762 | - |
| 313 | NEO | NeoGenomics, Inc. | 1.46B | 0.63% | 3,108,335 | 745.97M |
| 314 | SVRA | Savara Inc. | 1.44B | 3.45% | 2,291,438 | - |
| 315 | ATRC | AtriCure, Inc. | 1.44B | -1.25% | 696,567 | 552.16M |
| 316 | STAA | STAAR Surgical Company | 1.44B | -1.00% | 596,600 | 290.38M |
| 317 | MAZE | Maze Therapeutics, Inc. | 1.42B | -0.43% | 530,342 | 20.00M |
| 318 | COAG | Hemab Therapeutics Holdings, Inc. | 1.40B | 8.55% | 355,935 | - |
| 319 | AVLN | Avalyn Pharma Inc. | 1.38B | 4.83% | 503,897 | - |
| 320 | AKTS | Aktis Oncology, Inc. | 1.37B | 2.91% | 361,646 | 8.28M |
| 321 | IART | Integra LifeSciences Holdings Corporation | 1.37B | 0.11% | 841,317 | 1.64B |
| 322 | INBX | Inhibrx Biosciences, Inc. | 1.37B | 0.27% | 235,361 | 1.30M |
| 323 | TDOC | Teladoc Health, Inc. | 1.37B | -6.07% | 4,803,695 | 2.51B |
| 324 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.36B | 0.96% | 1,468,463 | 204.73M |
| 325 | MPLT | MapLight Therapeutics, Inc. | 1.35B | 3.37% | 654,833 | - |
| 326 | IMTX | Immatics N.V. | 1.34B | - | 553,615 | 43.00M |
| 327 | PRGO | Perrigo Company plc | 1.33B | -6.34% | 2,641,465 | 4.18B |
| 328 | ATEC | Alphatec Holdings, Inc. | 1.31B | -2.95% | 4,093,118 | 787.08M |
| 329 | ZBIO | Zenas BioPharma, Inc. | 1.31B | 5.16% | 643,448 | 10.00M |
| 330 | ABSI | Absci Corporation | 1.31B | 13.36% | 8,370,894 | 1.84M |
| 331 | ARDT | Ardent Health, Inc. | 1.29B | 1.35% | 410,169 | 6.43B |
| 332 | CDNA | CareDx, Inc. | 1.29B | -4.32% | 735,899 | 412.82M |
| 333 | AHCO | AdaptHealth Corp. | 1.29B | 0.10% | 1,394,600 | 3.29B |
| 334 | PAHC | Phibro Animal Health Corporation | 1.26B | -2.45% | 250,139 | 1.50B |
| 335 | INNV | InnovAge Holding Corp. | 1.25B | 2.68% | 363,524 | 949.17M |
| 336 | ENOV | Enovis Corporation | 1.23B | -3.05% | 1,097,600 | 2.28B |
| 337 | ALVO | Alvotech | 1.22B | -6.89% | 1,012,041 | 562.04M |
| 338 | BLFS | BioLife Solutions, Inc. | 1.22B | -4.38% | 660,209 | 101.66M |
| 339 | KMTS | Kestra Medical Technologies, Ltd. | 1.21B | 4.01% | 288,077 | 83.72M |
| 340 | MNKD | MannKind Corporation | 1.20B | -1.27% | 3,563,036 | 360.78M |
| 341 | PRCT | PROCEPT BioRobotics Corporation | 1.20B | -3.04% | 1,232,119 | 322.02M |
| 342 | INSP | Inspire Medical Systems, Inc. | 1.19B | -2.96% | 700,095 | 915.25M |
| 343 | XERS | Xeris Biopharma Holdings, Inc. | 1.19B | -0.72% | 1,692,337 | 314.85M |
| 344 | WVE | Wave Life Sciences Ltd. | 1.19B | 0.16% | 2,451,532 | 71.80M |
| 345 | AMN | AMN Healthcare Services, Inc. | 1.18B | -2.07% | 866,838 | 3.42B |
| 346 | IRMD | IRADIMED CORPORATION | 1.17B | -0.55% | 95,063 | 86.28M |
| 347 | PNTG | The Pennant Group, Inc. | 1.17B | 0.57% | 234,601 | 1.02B |
| 348 | AVNS | Avanos Medical, Inc. | 1.17B | -0.16% | 359,243 | 715.90M |
| 349 | JBIO | Jade Biosciences, Inc. | 1.15B | 15.64% | 1,869,890 | - |
| 350 | EYPT | EyePoint, Inc. | 1.15B | 1.10% | 842,462 | 7.61M |
| 351 | AHG | Akso Health Group | 1.15B | - | 18,216 | 14.84M |
| 352 | SDGR | Schrödinger, Inc. | 1.14B | -3.36% | 954,826 | 254.91M |
| 353 | COLL | Collegium Pharmaceutical, Inc. | 1.08B | -0.27% | 477,323 | 796.33M |
| 354 | OPK | OPKO Health, Inc. | 1.08B | 0.70% | 3,786,855 | 581.12M |
| 355 | OMDA | Omada Health, Inc. | 1.07B | 1.93% | 1,209,494 | 283.30M |
| 356 | PSNL | Personalis, Inc. | 1.07B | -3.51% | 2,506,301 | 64.52M |
| 357 | CGEM | Cullinan Therapeutics, Inc. | 1.06B | 15.10% | 1,497,018 | - |
| 358 | MGTX | MeiraGTx Holdings plc | 1.06B | 1.41% | 1,292,750 | 79.76M |
| 359 | CRVS | Corvus Pharmaceuticals, Inc. | 1.06B | 5.46% | 1,388,656 | - |
| 360 | XNCR | Xencor, Inc. | 1.04B | 10.84% | 1,203,501 | 97.36M |
| 361 | NUTX | Nutex Health Inc. | 1.03B | -0.23% | 155,311 | 879.95M |
| 362 | AZTA | Azenta, Inc. | 1.03B | -4.46% | 590,848 | 596.48M |
| 363 | SANA | Sana Biotechnology, Inc. | 1.01B | 6.67% | 3,762,221 | - |
| 364 | SPRY | ARS Pharmaceuticals, Inc. | 991.05M | 3.42% | 2,602,344 | 98.99M |
| 365 | CRON | Cronos Group Inc. | 989.41M | -2.21% | 784,566 | 159.54M |
| 366 | TNDM | Tandem Diabetes Care, Inc. | 982.71M | -6.27% | 2,451,801 | 1.03B |
| 367 | CNMD | CONMED Corporation | 979.75M | -0.12% | 1,015,981 | 1.37B |
| 368 | AORT | Artivion, Inc. | 977.18M | -5.00% | 628,758 | 458.69M |
| 369 | SPTX | Seaport Therapeutics, Inc. | 963.01M | -0.99% | 466,925 | - |
| 370 | LXRX | Lexicon Pharmaceuticals, Inc. | 955.02M | 6.97% | 3,035,728 | 69.64M |
| 371 | BIOA | BioAge Labs, Inc. | 954.40M | 3.37% | 458,640 | 10.32M |
| 372 | USPH | U.S. Physical Therapy, Inc. | 951.33M | -1.28% | 182,273 | 787.69M |
| 373 | EVO | Evotec SE | 949.98M | 2.34% | 41,061 | 859.03M |
| 374 | DBVT | DBV Technologies S.A. | 942.13M | 1.09% | 437,590 | 5.74M |
| 375 | AVR | Anteris Technologies Global Corp. | 933.51M | -1.94% | 1,013,637 | 1.85M |
| 376 | ORIC | ORIC Pharmaceuticals, Inc. | 924.41M | 5.18% | 1,808,807 | - |
| 377 | REPL | Replimune Group, Inc. | 923.16M | 9.72% | 3,108,230 | - |
| 378 | KURA | Kura Oncology, Inc. | 919.70M | 4.33% | 1,386,199 | 71.64M |
| 379 | PHAR | Pharming Group N.V. | 917.37M | -1.24% | 5,362 | 369.49M |
| 380 | LMRI | Lumexa Imaging Holdings, Inc. | 911.81M | 0.85% | 575,395 | 1.03B |
| 381 | DRTS | Alpha Tau Medical Ltd. | 904.47M | 2.56% | 567,928 | - |
| 382 | AVTX | Avalo Therapeutics, Inc. | 897.82M | 16.19% | 2,539,849 | 59.00K |
| 383 | ETON | Eton Pharmaceuticals, Inc. | 896.28M | 0.74% | 225,055 | 86.93M |
| 384 | PCRX | Pacira BioSciences, Inc. | 893.59M | 1.70% | 706,850 | 734.86M |
| 385 | ABUS | Arbutus Biopharma Corporation | 892.87M | -0.66% | 5,301,268 | 191.45M |
| 386 | ODTX | Odyssey Therapeutics, Inc. | 883.10M | -1.84% | 375,955 | 1.06M |
| 387 | JANX | Janux Therapeutics, Inc. | 874.52M | 0.84% | 911,752 | 13.73M |
| 388 | OLMA | Olema Pharmaceuticals, Inc. | 873.47M | 5.15% | 2,548,272 | - |
| 389 | TALK | Talkspace, Inc. | 872.74M | - | 3,209,891 | 238.37M |
| 390 | GDRX | GoodRx Holdings, Inc. | 870.40M | -3.38% | 1,869,490 | 787.89M |
| 391 | GERN | Geron Corporation | 859.64M | 6.35% | 18,713,542 | 196.12M |
| 392 | LBRX | LB Pharmaceuticals Inc | 856.57M | -0.43% | 345,039 | - |
| 393 | DSGN | Design Therapeutics, Inc. | 855.66M | 10.13% | 823,778 | - |
| 394 | TBPH | Theravance Biopharma, Inc. | 853.72M | -0.12% | 1,140,482 | 109.78M |
| 395 | PHAT | Phathom Pharmaceuticals, Inc. | 849.11M | -1.75% | 670,907 | 204.89M |
| 396 | QDEL | QuidelOrtho Corporation | 843.52M | -9.51% | 1,391,102 | 2.66B |
| 397 | INMD | InMode Ltd. | 836.97M | -1.42% | 721,843 | 374.64M |
| 398 | CERT | Certara, Inc. | 830.72M | -3.61% | 4,303,246 | 419.75M |
| 399 | ANNX | Annexon, Inc. | 825.77M | 2.86% | 3,039,599 | - |
| 400 | SLDB | Solid Biosciences Inc. | 817.13M | -0.36% | 1,964,518 | - |
| 401 | ESPR | Esperion Therapeutics, Inc. | 813.48M | 0.32% | 8,854,575 | 418.24M |
| 402 | EVMN | Evommune, Inc. | 812.21M | 5.57% | 517,513 | 10.00M |
| 403 | VOR | Vor Biopharma Inc. | 809.54M | 3.11% | 800,527 | - |
| 404 | AMPH | Amphastar Pharmaceuticals, Inc. | 808.22M | -2.55% | 767,439 | 720.53M |
| 405 | ANRO | Alto Neuroscience, Inc. | 804.70M | 0.84% | 366,747 | - |
| 406 | AURA | Aura Biosciences, Inc. | 766.58M | 9.62% | 635,641 | - |
| 407 | ZVRA | Zevra Therapeutics, Inc. | 747.81M | -1.94% | 1,120,059 | 122.29M |
| 408 | OMER | Omeros Corporation | 747.64M | 0.49% | 1,699,722 | 9.89M |
| 409 | HSTM | HealthStream, Inc. | 740.90M | -1.09% | 165,562 | 311.78M |
| 410 | GMRS | GMR Solutions Inc. | 739.96M | 3.40% | 892,757 | 5.83B |
| 411 | BVS | Bioventus Inc. | 734.27M | 0.92% | 575,335 | 576.30M |
| 412 | SLBT | SL Science Holding Limited | 730.55M | -21.93% | 349,068 | - |
| 413 | ALLO | Allogene Therapeutics, Inc. | 724.82M | 5.00% | 6,573,188 | 22.00K |
| 414 | NNNN | Anbio Biotechnology | 722.89M | -1.02% | 32,241 | 8.65M |
| 415 | RLMD | Relmada Therapeutics, Inc. | 722.69M | 2.38% | 1,440,971 | - |
| 416 | IVA | Inventiva S.A. | 714.31M | -1.68% | 862,500 | 7.94M |
| 417 | OCS | Oculis Holding AG | 704.73M | 4.01% | 480,712 | 1.40M |
| 418 | SIBN | SI-BONE, Inc. | 701.61M | -0.13% | 544,647 | 206.22M |
| 419 | CLYM | Climb Bio, Inc. | 697.43M | 6.38% | 1,431,166 | - |
| 420 | CRMD | CorMedix Inc. | 691.95M | 1.73% | 1,957,828 | 400.05M |
| 421 | CBLL | CeriBell, Inc. | 689.80M | 0.83% | 227,986 | 95.07M |
| 422 | ACRS | Aclaris Therapeutics, Inc. | 675.97M | 7.56% | 1,819,334 | 8.37M |
| 423 | SSII | SS Innovations International, Inc. | 672.44M | -3.17% | 40,160 | 48.47M |
| 424 | CADL | Candel Therapeutics, Inc. | 670.42M | 10.11% | 2,201,021 | - |
| 425 | IMMX | Immix Biopharma, Inc. | 669.19M | 7.80% | 1,393,720 | - |
| 426 | CTMX | CytomX Therapeutics, Inc. | 661.82M | 3.05% | 3,780,490 | 35.54M |
| 427 | RIGL | Rigel Pharmaceuticals, Inc. | 661.08M | 8.57% | 600,123 | 299.77M |
| 428 | SGP | SpyGlass Pharma, Inc. | 646.47M | 3.42% | 109,018 | - |
| 429 | CSTL | Castle Biosciences, Inc. | 642.99M | 0.38% | 429,413 | 339.92M |
| 430 | TRAX | First Tracks Biotherapeutics, Inc. | 639.23M | 5.17% | 524,642 | - |
| 431 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 630.44M | 4.10% | 939,129 | - |
| 432 | IRWD | Ironwood Pharmaceuticals, Inc. | 628.82M | 7.91% | 2,523,942 | 361.51M |
| 433 | TENX | Tenax Therapeutics, Inc. | 625.87M | 2.08% | 877,058 | - |
| 434 | DRUG | Bright Minds Biosciences Inc. | 618.56M | 4.67% | 348,098 | - |
| 435 | BBNX | Beta Bionics, Inc. | 610.50M | -1.30% | 952,219 | 110.24M |
| 436 | PRME | Prime Medicine, Inc. | 608.68M | 4.33% | 3,500,758 | 4.03M |
| 437 | AQST | Aquestive Therapeutics, Inc. | 592.12M | 0.21% | 1,937,035 | 50.27M |
| 438 | TCMD | Tactile Systems Technology, Inc. | 591.43M | -1.50% | 260,106 | 343.52M |
| 439 | DNA | Ginkgo Bioworks Holdings, Inc. | 590.53M | -1.42% | 872,492 | 151.40M |
| 440 | CBIO | Crescent Biopharma, Inc. | 583.83M | -0.68% | 307,151 | 11.88M |
| 441 | BWAY | BrainsWay Ltd. | 583.56M | -3.43% | 117,359 | 56.22M |
| 442 | AGMB | AgomAb Therapeutics NV | 583.10M | 7.83% | 126,015 | - |
| 443 | TECX | Tectonic Therapeutic, Inc. | 572.49M | 1.07% | 106,864 | - |
| 444 | ALT | Altimmune, Inc. | 569.81M | 8.52% | 5,776,511 | 36.00K |
| 445 | GYRE | Gyre Therapeutics, Inc. | 560.11M | -1.92% | 75,758 | 117.05M |
| 446 | PHR | Phreesia, Inc. | 551.36M | -4.90% | 1,255,111 | 495.59M |
| 447 | PROK | ProKidney Corp. | 549.75M | -0.55% | 728,575 | 889.00K |
| 448 | TLRY | Tilray Brands, Inc. | 547.51M | -2.96% | 3,525,618 | 858.28M |
| 449 | MDXG | MiMedx Group, Inc. | 546.63M | - | 1,111,124 | 389.42M |
| 450 | FDMT | 4D Molecular Therapeutics, Inc. | 544.72M | 7.87% | 1,695,280 | 88.24M |
| 451 | RZLT | Rezolute, Inc. | 538.00M | 2.59% | 3,111,906 | - |
| 452 | XOMA | XOMA Royalty Corporation | 526.72M | 0.26% | 105,515 | 48.56M |
| 453 | NPCE | NeuroPace, Inc. | 524.02M | -1.66% | 200,698 | 99.53M |
| 454 | ACHV | Achieve Life Sciences, Inc. | 523.56M | 5.15% | 2,899,458 | - |
| 455 | STRO | Sutro Biopharma, Inc. | 522.80M | 6.48% | 337,572 | 99.61M |
| 456 | CERS | Cerus Corporation | 520.96M | -3.70% | 1,935,386 | 216.56M |
| 457 | EIKN | Eikon Therapeutics, Inc. | 520.81M | 0.10% | 253,817 | - |
| 458 | ANGO | AngioDynamics, Inc. | 516.44M | 1.98% | 362,258 | 313.73M |
| 459 | CLPT | ClearPoint Neuro, Inc. | 511.62M | -4.00% | 870,026 | 40.61M |
| 460 | NGNE | Neurogene Inc. | 509.61M | 2.28% | 175,571 | 925.00K |
| 461 | FLGT | Fulgent Genetics, Inc. | 506.67M | -0.89% | 348,151 | 320.35M |
| 462 | KYTX | Kyverna Therapeutics, Inc. | 504.60M | 2.85% | 911,840 | - |
| 463 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 464 | EVH | Evolent Health, Inc. | 503.92M | -0.22% | 1,934,545 | 1.89B |
| 465 | TOI | The Oncology Institute, Inc. | 500.91M | -4.75% | 977,982 | 545.76M |
| 466 | VALN | Valneva SE | 500.27M | -0.56% | 7,409 | 180.25M |
| 467 | ARVN | Arvinas, Inc. | 499.39M | 0.91% | 711,452 | 89.40M |
| 468 | CTKB | Cytek Biosciences, Inc. | 498.49M | 2.39% | 1,885,408 | 204.17M |
| 469 | ASMB | Assembly Biosciences, Inc. | 498.40M | 2.91% | 286,842 | 71.10M |
| 470 | SRTA | Strata Critical Medical, Inc. | 497.53M | -2.21% | 1,209,390 | 228.58M |
| 471 | CABA | Cabaletta Bio, Inc. | 490.79M | 5.99% | 6,505,563 | - |
| 472 | CTEV | Claritev Corporation | 484.84M | -3.33% | 109,582 | 978.76M |
| 473 | PRTA | Prothena Corporation plc | 479.03M | 2.46% | 612,545 | 57.94M |
| 474 | RGNX | REGENXBIO Inc. | 468.90M | 16.28% | 9,094,401 | 87.82M |
| 475 | KIDS | OrthoPediatrics Corp. | 466.44M | -3.76% | 61,207 | 243.30M |
| 476 | MNPR | Monopar Therapeutics Inc. | 459.94M | 1.76% | 126,204 | - |
| 477 | MOBI | Mobia Medical, Inc. | 458.89M | -2.67% | 104,399 | 32.04M |
| 478 | CCCC | C4 Therapeutics, Inc. | 455.54M | -0.72% | 2,995,936 | 34.86M |
| 479 | ARTV | Artiva Biotherapeutics, Inc. | 454.79M | -4.68% | 464,754 | 251.00K |
| 480 | FBRX | Forte Biosciences, Inc. | 446.68M | 2.41% | 233,948 | - |
| 481 | SOPH | SOPHiA GENETICS SA | 439.57M | -2.20% | 354,582 | 81.18M |
| 482 | NRC | NRC Health | 439.24M | 5.12% | 153,504 | 138.64M |
| 483 | NVCT | Nuvectis Pharma, Inc. | 438.47M | 19.61% | 408,596 | - |
| 484 | SGMT | Sagimet Biosciences Inc. | 438.44M | 6.29% | 1,058,442 | - |
| 485 | VREX | Varex Imaging Corporation | 438.32M | -1.23% | 240,130 | 857.50M |
| 486 | OCGN | Ocugen, Inc. | 436.69M | 4.03% | 6,219,352 | 4.47M |
| 487 | CTNM | Contineum Therapeutics, Inc. | 434.43M | -2.68% | 195,996 | - |
| 488 | EOLS | Evolus, Inc. | 433.98M | -0.60% | 375,332 | 301.79M |
| 489 | EPRX | Eupraxia Pharmaceuticals Inc. | 432.67M | 2.47% | 432,273 | - |
| 490 | EDIT | Editas Medicine, Inc. | 429.69M | 4.09% | 2,919,011 | 38.69M |
| 491 | PRLD | Prelude Therapeutics Incorporated | 428.45M | - | 296,671 | 16.72M |
| 492 | INDP | Indaptus Therapeutics, Inc. | 427.49M | -3.21% | 162,998 | - |
| 493 | MYGN | Myriad Genetics, Inc. | 425.02M | -0.88% | 1,271,242 | 829.00M |
| 494 | BNTC | Benitec Biopharma Inc. | 422.56M | 1.23% | 119,895 | - |
| 495 | VTVT | vTv Therapeutics Inc. | 420.93M | -3.20% | 42,282 | 36.84M |
| 496 | OVID | Ovid Therapeutics Inc. | 419.94M | -0.88% | 2,568,841 | 7.12M |
| 497 | VMD | Viemed Healthcare, Inc. | 416.72M | 2.16% | 439,042 | 286.57M |
| 498 | ANL | Adlai Nortye Ltd. | 416.00M | 2.97% | 206,866 | 5.00M |
| 499 | IPSC | Century Therapeutics, Inc. | 414.82M | 0.44% | 965,290 | 109.16M |
| 500 | CGC | Canopy Growth Corporation | 414.34M | -1.04% | 3,933,956 | 203.89M |